Make your money go further for just 25p per day

Fyffes (AIM:FFY) – no slip ups from the banana distributor

27/08/2015 · Fyffes plc (FFY) 

The leading importer and distributor of tropical produce (bananas, pineapples and melons), which is dual listed on the Irish Enterprise Securities Market (ESM) as well as AIM, reported excellent interim results for six months ended 30 June 2015. Unusually for an AIM listed company it also offered earnings guidance for the full year. 

Group revenue for the 6 months ending 30th June 2015 rose 8.7% to €644.3m with diluted adjusted eps up 12.2%. 

Cash generation was very strong with operating profit of €31.1m resulting in an operating cash inflow of €39.1m with the Group moving from a net debt position of €11.7m at the beginning of the year to a net cash position of €18.6m at 30th June 2015.  All very positive on the debt front although…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Fyffes plc

An eventful week for the market, AIM and energy services in particular – opportunities galore!

28/08/2015 · Company Insights
Just when Grexit concerns had subsided, more pressing issues from China prompted a significant sell-off from…

Fyffes (AIM:FFY) – no slip ups from the banana distributor

27/08/2015 · Company Insights
The leading importer and distributor of tropical produce (bananas, pineapples and melons), which is dual listed…

More Company Insights

Elderly challenges | Demotion | Australian boost

21/11/2024 · Churchill China · CVS Group · Renold · Tracsis

Bonkers Bargains: poised to recover with a new CEO

20/11/2024 · James Cropper

Improving returns | Questionable business models

Sign-up to our free email updates

SIGN UP